Monalisa Das¹, Megha Pundir² and Sanjib Patra³*

¹PhD Scholar, Department of Microbiology, Bharathidasan University, Tiruchirapalli, India
²PhD Scholar, Department of Yoga, Central University of Rajasthan, Ajmer, Rajasthan, India
³PhD, Associate Professor, Department of Yoga, Central University of Rajasthan, Ajmer, Rajasthan, India

*Corresponding Author: Sanjib Patra, PhD, Associate Professor, Department of Yoga, Central University of Rajasthan, Ajmer, Rajasthan, India.

Received: August 21, 2023; Published: November 11, 2023

Abstract

The most prevalent global mental ailment, which primarily affects young women, is depression. Women are more sensitive to interpersonal interactions, hormonal changes before and during pregnancy, and menstrual periods each month. Women are more likely to develop a few conditions linked to depression than men, including autoimmunity, dysmenorrhea, CVD, and amenorrhea. Yoga is a form of alternative therapy that boosts mental ability by calming the mind and increasing physical activity. Yoga asana along with meditation may also create an equilibrium in the production of female sex hormones and maintain the immune system by bringing the body and mind into harmony.

Keywords: Depression; Yoga; CVD; Autoimmunity; Dysmenorrhea

References

1. Randall KL and Hawkins CA. “Antihistamines and allergy”. Australian Prescriber 2 (2018): 41-45.
2. Church MK and Church DS. “Pharmacology of antihistamines”. Indian Journal of Dermatology 3 (2013): 219-224.
3. Pons-Guiraud A., et al. “Emedastine di fumarate versus Loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial". European Journal of Dermatology6 (2006): 649-654.
4. Naclerio RM. “The role of histamine in allergic rhinitis”. The Journal of Allergy and Clinical Immunology 86 (1990):628-632.
5. Noor Jahan., et al. “Spectrophotometric determination of Loratadine in bulk and pharmaceutical dosage form”. International Journal of Pharma Sciences and Research05 (2018): 65-73.
6. Georgeta Pavalachea., et al. “Determination of Loratadine in pharmaceuticals by a spectrophotometric method”. Ovidius University Annals of Chemistry1 (2015): 27-31.
7. Prathap B., et al. “Analytical method development and validation for the estimation of Loratadine using UV spectrophotometer”. World Journal of Pharmaceutical Research6 (2023): 701-714.
8. Georgeta pavalache., et al. “Validation and application of a new DAD-HPLC method for the determination of Loratadine from pharmaceuticals”. Farmacia3 (2015): 366-370.
9. Moazameh peyrovi., et al. “Extraction optimization of Loratadine by supramolecular solvent-based microextraction and its determination using HPLC”. Journal of Chromatography 980 (2015): 41-47.
10. Kunicki PK. “Determination of Loratadine in human plasma by high-performance liquid chromatographic method with ultraviolet detection.”. Journal of Chromatography B 755 (2001): 331-335.
11. Samridhi., et al. “Validation of isocratic RP-HPLC method and UV spectrophotometric method for the estimation of Loratadine in pharmaceutical formulations”. Research Journal of Pharmacy and Technology 4 (2015): 452-461.
12. NA El Ragehy., et al. “Stability indicating methods for the determination of Loratadine in the presence of its degradation product”. Journal of Pharmaceutical and Biomedical Analysis6 (2002): 1041-1053.
13. Guptha AVN., et al. “New RP-HPLC method development and validation for the analysis of Loratadine in formulations”. International Journal of Research And Reviews In Pharmacy And Applied Sciences3 (2011): 179-185.
14. Adrian Florin Spac., et al. “Validation and application of an RP - HPLC method with UV detection for Loratadine determination”. Revista de Chimie6 (2016): 1227-1231.
15. Nagadani Swarnalatha., et al. “Development and validation of an HPLC method for estimation of Loratadine and its application to a pharmacokinetic study”. Current Science2 (2019): 243-248.
16. Gajjela Ramulu., et al. “A new validated liquid chromatographic method for the determination of Loratadine and its impurities”. Scientica pharmaceutica 79 (2011): 277-291.
17. Weng Naidong et al. “A sensitive LC/MS/MS method using silica column and aqueous/organic mobile phase for the analysis of Loratadine and Des carboethoxy-Loratadine in human plasma”. Journal of Pharmaceutical and Biomedical Analysis 32 (2003): 609-617.
18. Bhavin NP et al. “LC–MS-ESI for the determination of Loratadine and Des carbo ethoxy-Loratadine in human plasma”. Journal of Chromatographic Science 1 (2010): 35-44.
19. Rajaa F Hussein et al. “Rapid determination of Loratadine level in human plasma by LCMS/MS assay”. American Journal of Pharmatech Research3 (2018): 221-232.
20. Wenkui Li et al. “LC-MS/MS bioanalysis of Loratadine (Claritin) in dried blood spot (DBS) samples collected by subjects in a clinical research study”. 983-984 (2015): 117-124.
21. Nagwa AS et al. “Determination of Loratadine in human plasma by Liquid chromatography-tandem mass spectrometry (LC/MS/MS) and its pharmacokinetic application”. International Journal of Pharmaceutical Sciences Research 102 (2014): 1-6.
22. Isam Ismail Salem et al. “Determination of Loratadine in human plasma by liquid chromatography-electrospray ionization ion-trap tandem mass spectrometry”. Journal of Pharmaceutical and Biomedical Analysis 34 (2004): 141-151.
23. Dandan Yang et al. “Quantitative determination of Loratadine in rat plasma by LC-MS/MS method and its application in a bioavailability study”. Chromatographia 83 (2020): 183-190.

Citation

Citation: Paul H Hartel., et al. “Umbilical Cord Index and Placental Intervillous Thrombi: Implications for Clinical Management".Acta Scientific Women's Health 5.12 (2023): 03-05.

Copyright

Copyright: © 2023 Paul H Hartel., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.